• Explore /
  • Poster
  • / HER-FLOT: Trastuzumab in combination with FLOT as perioperative treatment for patients with HER2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the AIO Gastric Cancer Study Group.

HER-FLOT: Trastuzumab in combination with FLOT as perioperative treatment for patients with HER2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the AIO Gastric Cancer Study Group.

Abstract Poster

Authors

Ralf Hofheinz

Ralf Hofheinz

University Hospital Mannheim, Mannheim, Germany

Ralf Hofheinz , Susanna Hegewisch-Becker , Peter C. Thuss-Patience , Volker Kunzmann , Martin Fuchs , Ullrich Graeven , Nils Homann , Volker Heinemann , Michael Pohl , Andrea Tannapfel , Salah-Eddin Al-Batran

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

NCT01472029

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 4073^)

DOI

10.1200/jco.2014.32.15_suppl.4073

Abstract #

4073^

Poster Bd #

160

Abstract Disclosures

Similar Posters

First Author: Ralf Hofheinz

First Author: Salah-Eddin Al-Batran

First Author: Daniel Wilhelm Mueller

First Author: Salah-Eddin Al-Batran